Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma. Liu C, Zha Z, Zhou C, Chen Y, et al. J Hepatol 2020 Oct 5. pii: S0168-8278(20)33674.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu C, Zha Z, Zhou C, Chen Y, et al. Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma. J Hepatol 2020 Oct 5. pii: S0168-8278(20)33674.
PMID: 33031845